Skip to content

Clinical trials

Phase 1 Carcinoma, Renal Cell trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Renal Cell Phase: Phase 1 Clear all

426 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20007
20017
20023
20034
20048
200510
200615
20079
200816
200913
201014
201110
201215
201311
201413
201518
201624
201713
201818
201920
202031
202122
202224
202328
202420
202517
202622

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed218
Terminated75
Recruiting47
Active, not recruiting43
Unknown status18
Withdrawn9
Not yet recruiting9
Suspended7

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)31
Novartis Pharmaceuticals13
Pfizer13
M.D. Anderson Cancer Center11
GlaxoSmithKline9
Bristol-Myers Squibb8
Celldex Therapeutics7
City of Hope Medical Center7
Jonsson Comprehensive Cancer Center7
Memorial Sloan Kettering Cancer Center7

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Renal Cell426
Carcinoma, Non-Small-Cell Lung139
Melanoma133
Kidney Neoplasms91
Colorectal Neoplasms79
Ovarian Neoplasms69
Squamous Cell Carcinoma of Head and Neck69
Breast Neoplasms68
Neoplasms61
Carcinoma, Hepatocellular56

Trials

Showing 1 to 25 of 426. Each trial links to its page on Pharma Observatory.

326 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.